Citations

Showing 10 of 108083 citations.

Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials
Rahman, Ruman , Janowski, Mirosław , Killick-Cole, Clare, Singleton, William , Campbell, Emma , Walczak, Piotr , Khatua, Soumen , Faltings, Lukas , Symons, Marc , Schneider, Julia , Kwan, Kevin, Boockvar, John A. , Gill, Steven , Oliveira, Joaquím M. , Beccaria, Kévin , Carpentier, Alexandre , Canney, Michael , Veal, Gareth J. , Meijer, Lisethe , Walker, David , Oliveira, J Miguel , Veal, Gareth J , Meijer, Lisethe , Carpentier, Alexandre C. , Pearl, Monica Smith

Mayo Clinic

Cancers | January 30, 2023 | Volume: 15 | Issue: 3 | Pages: 857

10.3390/cancers15030857 | PMID 36765816 Get It

Brain and spinal tumors affect 1 in 1000 people by 25 years of age, and have diverse histological, biological, anatomical and dissemination characteristics. A mortality of 30–40% means the majority are cured, although two-thirds have life-long disability, linked to accumulated brain injury that is acquired prior to diagnosis, and after surgery or chemo-radiotherapy. Only four drugs have been licensed globally for brain tumors in 40 years and only one for children. Most new cancer drugs in clinical trials do not cross the blood–brain barrier (BBB). Techniques to enhance brain tumor drug delivery are explored in this review, and cover those that augment penetration of the BBB, and those that bypass the BBB. Developing appropriate delivery techniques could improve patient outcomes by ensuring efficacious drug exposure to tumors (including those that are drug-resistant), reducing systemic toxicities and targeting leptomeningeal metastases. Together, this drug delivery strategy seeks to enhance the efficacy of new drugs and enable re-evaluation of existing drugs that might have previously failed because of inadequate delivery. A literature review of repurposed drugs is reported, and a range of preclinical brain tumor models available for translational development are explored.
Extradural Primary Malignant Spinal Tumors in a Population Younger than 25 Years: An Ambispective International Multicenter Study on Onco-Surgical Outcomes
Disch, Alexander C. , Rhines, Laurence D. , Fisher, Charles G. , Gokaslan, Ziya L. , Chou, Dean , Fehlings, Michael G. , Schaser, Klaus‐Dieter , Germscheid, Nicole M., Reynolds, Jeremy , Tumor, The AO Spine Knowledge Forum, Reynolds, Jeremy , Fehlings, Michael G , Reynolds, Jeremy , Boriani, Stefano , Luzzati, Alessandro , Lazáry, Áron , Clarke, Michelle J. , Tumor, The AO Spine Knowledge Forum

Mayo Clinic

Cancers | January 30, 2023 | Volume: 15 | Issue: 3 | Pages: 845

10.3390/cancers15030845 | PMID 36765803 Get It

Extradural malignant primary spinal tumors are rare and outcome data, especially for younger patients, is limited. In a worldwide (11 centers) study (Predictors of Mortality and Morbidity in the Surgical Management of Primary Tumors of the Spine study; ClinicalTrials.gov Identifier NCT01643174) by the AO Spine Knowledge Forum Tumor, patients surgically treated for primary tumors of the spine between 1992 and 2012, were retrospectively analyzed from a prospective database of their medical history. Medical history, tumor characteristics, diagnostics, treatments, cross-sectional survival, and local recurrences were analyzed. Sixty-eight cases (32 f; 36 m), at an average age of 18.6 ± 4.7 years at the time of diagnosis, were identified (median follow-up 2.9 years). The most common entities were Ewing’s sarcoma (42.6%). Of the patients, 28% had undergone previous spine tumor surgery in another center (84% with intralesional margins). Resection was considered “Enneking appropriate” (EA) in 47.8% of the cases. Of the patients, 77.9% underwent chemotherapy and 50% radiotherapy. A local recurrence occurred in 36.4%. Over a third of patients died within a 10-year follow-up period. Kaplan-Meier-analysis demonstrated statistically significant overall survival (p = 0.007) and local recurrence rates (p = 0.042) for tumors treated with EA surgery versus Enneking inappropriate surgery. Aggressive resection of extradural primary malignant spinal tumors combined with adjuvant therapy reveals low local recurrence rates and better outcomes overall in younger patients.
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States
Abdelrahman, Amro M. , Yin, Jun , Yonkus, Jennifer A. , Leiting, Jennifer L. , Lynch, Isaac T. , Campbell, Nellie A. , Carlson, Danielle M. , Roberts, Lewis R. , Gores, Gregory J. , Smoot, Rory L. , Hálfdánarson, Þorvarður R. , Truty, Mark J. , Gores, Gregory J. , Alva-Ruiz, Roberto, Yonkus, Jennifer A , Fogliati, Alessandro, Campbell, Nellie A , Roberts, Lewis R , Halfdanarson, Thorvardur R , Smoot, Rory L , Yin, Jun , Abdelrahman, Amro M , Alva‐Ruiz, Roberto , Fogliati, Alessandro , Carlson, Danielle Marie , Graham, Rondell P.

Mayo Clinic

Cancers | January 30, 2023 | Volume: 15 | Issue: 3 | Pages: 840

10.3390/cancers15030840 | PMID 36765798 Get It

Mixed acinar neuroendocrine carcinoma of the pancreas (MANEC-P) is an extremely rare malignancy with a poor prognosis. However, epidemiological estimates of MANEC-P remain unknown. This study aimed to estimate and compare the incidence, prevalence, and cancer-specific survival (CSS) of MANEC-P in the United States (US). Patients with MANEC-P were identified through the Surveillance, Epidemiology, and End Results (SEER) and National Program of Cancer Registries databases between 2000–2017. The primary outcomes included age-adjusted incidence rate, limited-duration prevalence, and CSS. A total of 630 patients were identified for the incidence analysis and 149 for the prevalence and CSS analyses. The MANEC-P incidence rate was 0.011 per 100,000 individuals, which was the lowest among pancreatic cancer histologic subtypes. The incidence rate was significantly higher in men and Black races and peaked at 75–79 years of age. The incidence rate was the lowest in the midwestern region (0.009) and the highest in the northeastern US (0.013). The 17-year prevalence was 0.00005%, indicating that 189 patients were alive in the United States at the beginning of 2018. The median CSS of MANEC-P was estimated to be 41 (23, 69) months. In conclusion, MANEC-P is very rare, and its incidence rate has been steady in the US over the last two decades. MANEC-P has a poor prognosis and is the 5th leading cause of pancreatic cancer-related death in the US.
Disparities in vaccination rates in solid organ transplant patients
Felzer, Jamie , Beam, Elena , Juhn, Young J. , Kennedy, Cassie C. , Felzer, Jamie R , Beam, Elena , Jacobson, Robert M. , Kennedy, Cassie C , Rutten, Lila J. Finney , Wi, Chung‐Il , LeMahieu, Allison

Mayo Clinic

Transplant Infectious Disease | January 30, 2023 | Volume: 25 | Issue: 2 | Pages: No page available

10.1111/tid.14010 | PMID 36715676 Get It

Abstract Introduction Vaccinations against preventable respiratory infections such as Streptococcus pneumoniae and influenza are important in immunosuppressed solid organ transplant (SOT) recipients. Little is known about the role of age, race, ethnicity, sex, and sociodemographic factors including rurality, or socioeconomic status (SES) associated with vaccine uptake in this population. Methods We conducted a population‐based study using the Rochester Epidemiology Project, a medical records linkage system, to assess socioeconomic and demographic factors associated with influenza and pneumococcal vaccination rates among adult recipients of solid organ transplantation (aged 19–64 years) living in four counties in southeastern Minnesota. Vaccination data were obtained from the Minnesota Immunization Information Connection from June 1, 2010 to June 30, 2020. Vaccination rate was assessed with Poisson and logistic regression models. Results A total of 468 SOT recipients were identified with an overall vaccination rate of 57%–63% for influenza and 56% for pneumococcal vaccines. As expected, vaccination for pneumococcal vaccine positively correlated with influenza vaccination. Rural patients had decreased vaccination in both compared to urban patients, even after adjusting for age, sex, race, ethnicity, and SES. Although the population was mostly White and non‐Hispanic, neither vaccination differed by race or ethnicity, but influenza vaccination did by SES. Among organ transplant groups, liver and lung recipients were least vaccinated for influenza, and heart recipients were least up‐to‐date on pneumococcal vaccines. Conclusions Rates of vaccination were below national goals. Rurality was associated with undervaccination. Further investigation is needed to understand and address barriers to vaccination among transplant recipients. image
Leptotrichia Bacteremia: 10-Year Retrospective Clinical Analysis and Antimicrobial Susceptibility Profiles
Ranganath, Nischal , Shirley, Joshua D. , Kind, Dalton R., Comba, Işın Y. , Patel, Robin , Schuetz, Audrey N. , Shah, Aditya , Challener, Douglas W. , Comba, Isin Y , Patel, Robin , Schuetz, Audrey N , Shah, Aditya S , Ranganath, Nischal , Stevens, Ryan W.

Mayo Clinic

Journal of Clinical Microbiology | January 30, 2023 | Volume: 61 | Issue: 2 | Pages: No page available

10.1128/jcm.01733-22 | PMID 36715514 Get It

Leptotrichia species are anaerobic, Gram-negative bacilli increasingly recognized as pathogens capable of causing invasive infections such as bloodstream infection (BSI), particularly among immunocompromised patients. However, there is a paucity of data regarding epidemiology, antimicrobial susceptibility, optimal treatment, and clinical outcomes among patients with Leptotrichia bacteremia.
Novel precision therapies for cholangiocarcinoma: an overview of clinical trials
Usón, Pedro Luiz Serrano , Bearss, Jeremiah J., Uson, Pedro L S , Bearss, Jeremiah, Babiker, Hani M. , Borad, Mitesh J.

Mayo Clinic

Expert Opinion on Investigational Drugs | January 30, 2023 | Volume: 32 | Issue: 1 | Pages: 69-75

10.1080/13543784.2023.2173064 | PMID 36714945 Get It

Long-Interval Intracortical Inhibition and the Cortical Silent Period in Youth
Ahern, Kelly B. , Garzon, Juan F. , Yuruk, Deniz , Saliba, Maria , Özger, Can , Voort, Jennifer L. Vande , Croarkin, Paul E. , Vande Voort, Jennifer L , Croarkin, Paul E

Mayo Clinic

Biomedicines | January 30, 2023 | Volume: 11 | Issue: 2 | Pages: 409

10.3390/biomedicines11020409 | PMID 36830945 Get It

Background: The cortical silent period (CSP) and long-interval intracortical inhibition (LICI) are putative markers of γ-aminobutyric acid receptor type B (GABAB)-mediated inhibitory neurotransmission. We aimed to assess the association between LICI and CSP in youths. Methods: We analyzed data from three previous studies of youth who underwent CSP and LICI measurements with transcranial magnetic stimulation and electromyography. We assessed CSP and LICI association using Spearman rank correlation tests and multiple linear regression analyses adjusted for demographic and clinical covariates. Results: The sample included 16 healthy participants and 45 participants with depression. The general mean (SD) age was 15.5 (1.7), 14.3 (1.7) for healthy participants, and 15.9 (1.6) years for participants with depression. Measures were nonnormally distributed (Shapiro–Wilk, p < 0.001). CSP and LICI were not correlated at 100-millisecond (ρ = −0.2421, p = 0.06), 150-millisecond (ρ = −0.1612, p = 0.21), or 200-millisecond (ρ = −0.0507, p = 0.70) interstimulus intervals using Spearman rank correlation test. No correlations were found in the multiple regression analysis (p = 0.35). Conclusions: Although previous studies suggest that cortical silent period and long-interval intracortical inhibition measure GABAB receptor-mediated activity, these biomarkers were not associated in our sample of youths. Future studies should focus on the specific physiologic and pharmacodynamic properties assessed by CSP and LICI in younger populations.
Impact of Tumor‐Infiltrating Lymphocytes on Disease Progression in Human Papillomavirus‐Related Oropharyngeal Carcinoma
Rivera, Michael , García, Joaquín J. , Lewis, Derrick B. , Lohse, Christine M. , Moore, Eric J. , Abel, Kathryn M. Van , Yin, Linda X , Bartemes, Kathleen R. , Van Abel, Kathryn M , Yin, Linda X. , Routman, David M. , Daniel, J.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 30, 2023 | Volume: 169 | Issue: 3 | Pages: 539-547

10.1002/ohn.249 | PMID 36939471 Get It

AbstractObjectiveWe aim to explore the prognostic value of tumor‐infiltrating lymphocytes (TILs) in the primary tumor and metastatic lymph nodes of patients with HPV(+)OPSCC. We hypothesize that TILS density at both sites is associated with disease‐free survival in HPV(+)OPSCC.Study DesignMatched case‐control study among HPV(+)OPSCC patients who underwent intent‐to‐cure surgery. Cases developed locoregional or distant recurrence. Controls were matched based on age, sex, pathologic T, N, and overall stage, year of surgery, type of adjuvant treatment received, and the Adult Comorbidity Evaluation‐27 (ACE‐27) score.SettingSingle tertiary care center, May 2007 to December 2016.MethodsTumoral TILs (tTILs) density was defined as % TILs; stromal TILs (sTILs) density was defined as absent/sparse or moderate/dense crowding. Associations between TILs and time to disease progression were assessed using Cox regression models.ResultsForty‐four case‐control pairs (N = 88) were included: 42 (48%) AJCC pStage I, 39 (44%) pStage II, and 7 (8%) pStage III. tTILs density ≥10% (hazard ratio [HR] 0.41, 95% confidence interval [CI] 0.17‐0.99, p = .048) and a moderate/dense sTILs density (HR 0.21, 95% CI 0.06‐0.75, p = .016) in the primary tumor were significantly associated with decreased risk of progression. TILs density in the lymph node was associated with decreased risk of progression but did not reach statistical significance. The tTILs and sTILs density correlated strongly between the primary tumor and lymph node. Concordance between the pathologists' was moderate (60%‐70%).ConclusionsIn HPV(+)OPSCC, a higher density of tumoral and stromal TILs in the primary tumor and possibly the lymph node may predict a lower risk of disease progression.
Letter: diet‐responsive or just diet‐adherent in EoE. Where is the dietitian? Authors' reply
Wang, Lillian , Alexander, Jeffrey A.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | January 30, 2023 | Volume: 57 | Issue: 4 | Pages: 445-445

10.1111/apt.17350 | PMID 36710541 Get It

LINKED CONTENTThis article is linked to Wang et al papers. To view these articles, visit https://doi.org/10.1111/apt.17221 and https://doi.org/10.1111/apt.17312
Clonogenic Survival RBE Calculations in Carbon Ion Therapy: The Importance of the Absolute Values of α and β in the Photon Dose-Response Curve and a Strategy to Mitigate Their Anticorrelation
Parisi, Alessio , Furutani, Keith M. , Parisi, Alessio , Furutani, Keith M , Beltran, Chris

Mayo Clinic

Quantum Beam Science | January 30, 2023 | Volume: 7 | Issue: 1 | Pages: 3

10.3390/qubs7010003 Get It

The computation of the relative biological effectiveness (RBE) is a fundamental step in the planning of cancer radiotherapy treatments with accelerated ions. Numerical parameters derived analyzing the dose response of the chosen cell line after irradiation to photons (i.e., α and β, namely the linear and quadratic terms of the linear-quadratic model of cell survival) are generally used as input to biophysical models to predict the ion RBE. The α/β ratio for the photon exposure is generally regarded as an indicator of cell radiosensitivity. However, previous studies suggest that α/β might not be a sufficient parameter to model the RBE of relatively high linear energy transfer (LET) radiation such as carbon ions. For a fixed α/β, the effect of the absolute values of α and β on the computed RBE is underexplored. Furthermore, since α and β are anticorrelated during the fit of the photon-exposed in vitro survival data, different linear-quadratic fits could produce different sets of α and β, thus affecting the RBE calculations. This article reports the combined effect of the α/β ratio and the absolute values α and β on the RBE computed with the Mayo Clinic Florida microdosimetric kinetic model (MCF MKM) for 12C ions of different LET. Furthermore, we introduce a theory-based strategy to potentially mitigate the anticorrelation between α and β during the fit of the photon dose-response biological data.